Details of the Probe-central Interaction Altas
General Information of Experiment
| Probe Name | C237 | Probe Info | ||||
|---|---|---|---|---|---|---|
| Probe concentration | Probe:50uM; negative probe:50uM | |||||
| Criteria | Quantification: AfBPP Probe vs Negative Probe | |||||
| Quantitative Method |
TMT
|
|||||
| In Vivo Experiment Model | Model Type |
|
Living cell | |||
| Derived Tissue |
|
Peripheral blood | ||||
| Disease Model | Normal | |||||
| Model Name | Human normal cells (HEK-293T) | |||||
| Note | Negative probe:C#CCCC1(CCC(NC)=O)N=N1 | |||||
Interaction Altas of This Experiment [1]
Enzyme
| Target ID | Target Name | Binding Ratio | ||||
|---|---|---|---|---|---|---|
| LDTP16032 | Retinoid-inducible serine carboxypeptidase (SCPEP1) | 18.6 | ||||
| LDTP00428 | Tripeptidyl-peptidase 1 (TPP1) | 16.0 | ||||
| LDTP13358 | Leucyl-cystinyl aminopeptidase (LNPEP) | 13.7 | ||||
| LDTP09256 | Putative phospholipase B-like 2 (PLBD2) | 13.5 | ||||
| LDTP02799 | N-acetylglucosamine-6-sulfatase (GNS) | 13.2 | ||||
| LDTP13620 | Lysosomal thioesterase PPT2 (PPT2) | 12.6 | ||||
| LDTP00316 | Ribonuclease T2 (RNASET2) | 12.2 | ||||
| LDTP03692 | Bifunctional epoxide hydrolase 2 (EPHX2) | 11.0 | ||||
| LDTP02486 | Lysosomal alpha-glucosidase (GAA) | 10.9 | ||||
| LDTP02141 | Alpha-galactosidase A (GLA) | 10.7 | ||||
| LDTP04008 | Endothelin-converting enzyme 1 (ECE1) | 10.7 | ||||
| LDTP01372 | Carboxypeptidase D (CPD) | 10.3 | ||||
| LDTP15988 | Probable serine carboxypeptidase CPVL (CPVL) | 10.2 | ||||
| LDTP10888 | Legumain (LGMN) | 9.3 | ||||
| LDTP06370 | Ephrin type-A receptor 7 (EPHA7) | 8.6 | ||||
| LDTP01241 | Bis(monoacylglycero)phosphate synthase CLN5 (CLN5) | 8.4 | ||||
| LDTP02539 | Lysosomal acid phosphatase (ACP2) | 8.3 | ||||
| LDTP04388 | Palmitoyl-protein thioesterase 1 (PPT1) | 8.0 | ||||
| LDTP02169 | Beta-hexosaminidase subunit alpha (HEXA) | 7.9 | ||||
| LDTP02006 | Tissue alpha-L-fucosidase (FUCA1) | 7.2 | ||||
| LDTP09886 | Gamma-glutamyl hydrolase (GGH) | 7.0 | ||||
| LDTP01333 | Isocitrate dehydrogenase [NADP] cytoplasmic (IDH1) | 6.8 | ||||
| LDTP00338 | Lysosomal alpha-mannosidase (MAN2B1) | 6.6 | ||||
| LDTP04004 | Lysosomal Pro-X carboxypeptidase (PRCP) | 6.6 | ||||
| LDTP11215 | Plasma alpha-L-fucosidase (FUCA2) | 6.6 | ||||
| LDTP04572 | Dipeptidyl peptidase 1 (CTSC) | 6.5 | ||||
| LDTP05905 | Acid ceramidase (ASAH1) | 6.4 | ||||
| LDTP02505 | Lysosomal protective protein (CTSA) | 6.2 | ||||
| LDTP02896 | Sphingomyelin phosphodiesterase (SMPD1) | 6.1 | ||||
| LDTP08476 | 5'-3' exonuclease PLD3 (PLD3) | 5.8 | ||||
| LDTP04634 | Alpha-N-acetylglucosaminidase (NAGLU) | 5.8 | ||||
| LDTP04211 | Isocitrate dehydrogenase [NADP], mitochondrial (IDH2) | 5.7 | ||||
| LDTP00783 | Beta-1,4-glucuronyltransferase 1 (B4GAT1) | 5.1 | ||||
| LDTP02837 | Beta-galactosidase (GLB1) | 4.9 | ||||
Transporter and channel
| Target ID | Target Name | Binding Ratio | ||||
|---|---|---|---|---|---|---|
| LDTP02215 | Prosaposin (PSAP) | 15.5 | ||||
| LDTP02586 | Cation-independent mannose-6-phosphate receptor (IGF2R) | 12.9 | ||||
| LDTP02071 | Amyloid-beta precursor protein (APP) | 12.2 | ||||
| LDTP05538 | Prolow-density lipoprotein receptor-related protein 1 (LRP1) | 10.7 | ||||
| LDTP04940 | NPC intracellular cholesterol transporter 2 (NPC2) | 9.9 | ||||
| LDTP00321 | Podocalyxin (PODXL) | 9.8 | ||||
| LDTP01829 | Low-density lipoprotein receptor (LDLR) | 9.8 | ||||
| LDTP10885 | Sortilin (SORT1) | 9.8 | ||||
| LDTP00865 | Mitochondrial carnitine/acylcarnitine carrier protein (SLC25A20) | 9.3 | ||||
| LDTP01969 | Transferrin receptor protein 1 (TFRC) | 9.3 | ||||
| LDTP06034 | Lysosome membrane protein 2 (SCARB2) | 7.8 | ||||
| LDTP17641 | Solute carrier family 35 member F2 (SLC35F2) | 7.5 | ||||
| LDTP10958 | Sigma non-opioid intracellular receptor 1 (SIGMAR1) | 7.4 | ||||
| LDTP11615 | Protein tweety homolog 3 (TTYH3) | 6.9 | ||||
| LDTP02562 | Lysosome-associated membrane glycoprotein 1 (LAMP1) | 6.6 | ||||
| LDTP05356 | Desmocollin-2 (DSC2) | 6.5 | ||||
| LDTP05218 | Low-density lipoprotein receptor-related protein 2 (LRP2) | 6.0 | ||||
| LDTP04459 | H(+)/Cl(-) exchange transporter 3 (CLCN3) | 5.9 | ||||
| LDTP02655 | Lysosome-associated membrane glycoprotein 2 (LAMP2) | 5.8 | ||||
| LDTP06499 | V-type proton ATPase subunit S1 (ATP6AP1) | 5.7 | ||||
| LDTP02166 | Integrin alpha-V (ITGAV) | 5.4 | ||||
| LDTP00541 | NPC intracellular cholesterol transporter 1 (NPC1) | 5.4 | ||||
| LDTP15481 | Transmembrane protein 87A (TMEM87A) | 5.1 | ||||
| LDTP01427 | Slit homolog 2 protein (SLIT2) | 5.1 | ||||
| LDTP11826 | Sodium-dependent neutral amino acid transporter B(0)AT2 (SLC6A15) | 5.0 | ||||
Immunoglobulin
| Target ID | Target Name | Binding Ratio | ||||
|---|---|---|---|---|---|---|
| LDTP04720 | IgG receptor FcRn large subunit p51 (FCGRT) | 14.6 | ||||
| LDTP09907 | Neogenin (NEO1) | 11.9 | ||||
Cytokine and receptor
| Target ID | Target Name | Binding Ratio | ||||
|---|---|---|---|---|---|---|
| LDTP02775 | Interferon gamma receptor 1 (IFNGR1) | 7.6 | ||||
Other
| Target ID | Target Name | Binding Ratio | ||||
|---|---|---|---|---|---|---|
| LDTP00779 | Trans-Golgi network integral membrane protein 2 (TGOLN2) | 17.0 | ||||
| LDTP07703 | Seizure 6-like protein 2 (SEZ6L2) | 16.2 | ||||
| LDTP10023 | Lethal(3)malignant brain tumor-like protein 2 (L3MBTL2) | 12.4 | ||||
| LDTP19780 | Keratinocyte-associated transmembrane protein 2 (KCT2) | 12.0 | ||||
| LDTP05491 | Amyloid beta precursor like protein 2 (APLP2) | 11.7 | ||||
| LDTP09054 | Golgi membrane protein 1 (GOLM1) | 7.8 | ||||
| LDTP15623 | Neuferricin (CYB5D2) | 7.8 | ||||
| LDTP06154 | Desmocollin-3 (DSC3) | 7.7 | ||||
| LDTP02927 | Ganglioside GM2 activator (GM2A) | 7.3 | ||||
| LDTP08081 | Hepatoma-derived growth factor-related protein 2 (HDGFL2) | 7.2 | ||||
| LDTP07031 | Collectin-12 (COLEC12) | 6.9 | ||||
| LDTP07934 | Synaptic vesicle glycoprotein 2A (SV2A) | 6.9 | ||||
| LDTP09920 | Golgi apparatus protein 1 (GLG1) | 6.0 | ||||
| LDTP14458 | Tetraspanin-6 (TSPAN6) | 5.5 | ||||
